[THE BEHAVIOR OF TRANSAMINASES (GOT, GPT) AND DEHYDROGENASES (LDH, MDH) IN THE SERUM AFTER CYTOSTATIC TREATMENT IN CARCINOMA PATIENTS].
D000410:Alanine Transaminase; D000970:Antineoplastic Agents; D001219:Aspartate Aminotransferases; D001774:Blood Chemical Analysis; D001943:Breast Neoplasms; D003520:Cyclophosphamide; D051263:D-Alanine Transaminase; D005260:Female; D005833:Genital Neoplasms, Female; D006801:Humans; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D010088:Oxidoreductases; D000637:Transaminases
D000970:Antineoplastic Agents; D003520:Cyclophosphamide; D010088:Oxidoreductases; D007770:L-Lactate Dehydrogenase; D008291:Malate Dehydrogenase; D000637:Transaminases; D001219:Aspartate Aminotransferases; D000410:Alanine Transaminase; D051263:D-Alanine Transaminase
ALANINE AMINOTRANSFERASE; ANTINEOPLASTIC AGENTS; ASPARTATE AMINOTRANSFERASE; BLOOD CHEMICAL ANALYSIS; BREAST NEOPLASMS; CYCLOPHOSPHAMIDE; GYNECOLOGIC NEOPLASMS; LACTATE DEHYDROGENASE; MALATE DEHYDROGENASE
DAS VERHALTEN DER TRANSAMINASEN (GOT, GPT) UND DEHYDROGENASEN (LDH, MDH) IM SERUM NACH CYTOSTATICABEHANDLUNG BEI CARCINOMPATIENTINNEN.